1
|
Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.16
|
2
|
Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.
|
Acta Oncol
|
2012
|
0.85
|
3
|
Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells.
|
J Neurooncol
|
2007
|
0.82
|
4
|
Depth profile characterization of ultra shallow junction implants.
|
Anal Bioanal Chem
|
2009
|
0.80
|
5
|
A new mathematical pharmacodynamic model of clonogenic cancer cell death by doxorubicin.
|
J Pharmacokinet Pharmacodyn
|
2013
|
0.79
|
6
|
Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines.
|
Nucleosides Nucleotides Nucleic Acids
|
2014
|
0.78
|